- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Assessing the Benefits of CT Colonography
In a recent video interview, Syam Reddy, MD discussed the merits of computed tomography (CT) colonography, a non-invasive alternative to conventional colonoscopy, which may help reduce gaps in screening for colorectal cancer.
Preventive screenings decreased significantly during the COVID-19 pandemic and colorectal cancer screening was no exception. While the number of people getting colorectal cancer screening will likely rise with increasing numbers of people receiving full vaccination for COVID-19, there are still significant screening gaps, according to Syam Reddy, MD, the Clinical Chairman at UChicago Medicine Ingalls Memorial Hospital.
In a new video interview, Dr. Reddy said the use of computed tomography (CT) colonography can provide an array of benefits in the realm of colorectal cancer screening.
Dr. Reddy said CT colonography provides better detection of cancerous and pre-cancerous lesions than other non-invasive testing measures such as stool testing, He noted CT colonography has comparable detection rates to conventional colonoscopy but offers patients the practical benefits of no sedation and milder preparation prior to the procedure.
Researchers have also demonstrated that preoperative use of CT colonography changed surgical management in over 20 percent of patients with occlusive colorectal cancer, which Dr. Reddy pointed out during a recent lecture on CT colonography at the Society of Abdominal Radiology (SARS) meeting.
Dr. Reddy also noted that CT colonography enables clinicians to perform simultaneous screening for osteoporosis and non-alcoholic fatty liver disease (NAFLD).
For more insights from Dr. Reddy on CT colonography, watch the video below:
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
